{"DataElement":{"publicId":"10625889","version":"1","preferredName":"Pharmacogenomic Test Performed Biomarker Type","preferredDefinition":"The text term that describes the type of pharmacogenomic test biomarkers.","longName":"PGX_BM_TYP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"10625881","version":"1","preferredName":"Pharmacogenomic Test Performed","preferredDefinition":"An assay intended to study interindividual variations in whole genome or candidate gene maps, biomarkers, and alterations in gene expression or inactivation that may be correlated with pharmacological function and therapeutic response. Compare to pharmacogenetic test.:Executed and carried through to completion.","longName":"6944198v1.00:10625880v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"11475058","version":"1","preferredName":"Pharmacogenomic Test","preferredDefinition":"An assay intended to study interindividual variations in whole genome or candidate gene maps, biomarkers, and alterations in gene expression or inactivation that may be correlated with pharmacological function and therapeutic response. Compare to pharmacogenetic test.","longName":"C68762","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacogenomic Test","conceptCode":"C68762","definition":"An assay intended to study interindividual variations in whole genome or candidate gene maps, biomarkers, and alterations in gene expression or inactivation that may be correlated with pharmacological function and therapeutic response. Compare to pharmacogenetic test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB52F8BC-4D62-5472-E053-731AD00AB39E","latestVersionIndicator":"Yes","beginDate":"2022-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-18","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435028","version":"1","preferredName":"Gene Product","preferredDefinition":"A protein or RNA whose structure is represented in and determined by genomic sequences.","longName":"C26548","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8320-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B4B7A-AB0F-76EF-E053-731AD00AA62C","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":"2022.10.18 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10625883","version":"1","preferredName":"Biomarker Type","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._Something distinguishable as an identifiable class based on common qualities.","longName":"10625883v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CD1a","valueDescription":null,"ValueMeaning":{"publicId":"3265095","version":"1","preferredName":"CD1A Gene","longName":"3265095","preferredDefinition":"This gene is involved in antigen presentation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD1A Gene","conceptCode":"C97921","definition":"This gene is involved in antigen presentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABA713F4-B5EB-599B-E040-BB89AD43023D","latestVersionIndicator":"Yes","beginDate":"2011-08-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-08-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C3-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Langerin (CD207)","valueDescription":null,"ValueMeaning":{"publicId":"10625884","version":"1","preferredName":"Langerin (CD207)","longName":"10625884v1.00","preferredDefinition":"Langerin (CD207)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B92ED-83BE-08C6-E053-731AD00A9836","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C4-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"S100","valueDescription":null,"ValueMeaning":{"publicId":"3412073","version":"1","preferredName":"S100 Calcium Binding Protein","longName":"3412073","preferredDefinition":"Encoded by S100 Family Gene members, S100 Calcium Binding Proteins, localized in the cytoplasm and/or nucleus of many cells, often regulate cellular processes such as cell cycle progression and differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S100 Calcium Binding Protein","conceptCode":"C29924","definition":"A family of low molecular weight proteins that are characterized by the presence of two EF-hand calcium binding domains. These proteins form homodimers that localize either in the cytoplasm or nucleus of neural crest-derived cells and are involved in the regulation of many cellular processes such as cell cycle progression and differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAC11F8D-C01C-FF2B-E040-BB89AD43414D","latestVersionIndicator":"Yes","beginDate":"2012-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-03-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C5-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"BRAF VE1","valueDescription":null,"ValueMeaning":{"publicId":"10625885","version":"1","preferredName":"BRAF VE1","longName":"10625885v1.00","preferredDefinition":"BRAF VE1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B92ED-83BF-08C6-E053-731AD00A9836","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C6-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"P-ERK","valueDescription":null,"ValueMeaning":{"publicId":"10625886","version":"1","preferredName":"EIF2AK3 wt Allele","longName":"10625886v1.00","preferredDefinition":"Human EIF2AK3 wild-type allele is located in the vicinity of 2p12 and is approximately 71 kb in length. This allele, which encodes eukaryotic translation initiation factor 2-alpha kinase 3 protein, is involved in both protein phosphorylation and the negative regulation of translation. Mutation of the gene is associated with Wolcott-Rallison syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EIF2AK3 wt Allele","conceptCode":"C102828","definition":"Human EIF2AK3 wild-type allele is located in the vicinity of 2p12 and is approximately 71 kb in length. This allele, which encodes eukaryotic translation initiation factor 2-alpha kinase 3 protein, is involved in both protein phosphorylation and the negative regulation of translation. Mutation of the gene is associated with Wolcott-Rallison syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B92ED-83C0-08C6-E053-731AD00A9836","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C7-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"CD68","valueDescription":null,"ValueMeaning":{"publicId":"3287978","version":"1","preferredName":"CD68 gene","longName":"3287978","preferredDefinition":"This gene may be involved in macrophage homing, selectin recognition and pathogen uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD68 Gene","conceptCode":"C88921","definition":"This gene may be involved in macrophage homing, selectin recognition and pathogen uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE2D37FC-F69B-89E7-E040-BB89AD437AF7","latestVersionIndicator":"Yes","beginDate":"2011-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C8-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Factor 13A","valueDescription":null,"ValueMeaning":{"publicId":"10625887","version":"1","preferredName":"TNFSF13 wt Allele","longName":"10625887v1.00","preferredDefinition":"Human TNFSF13 wild-type allele is located in the vicinity of 17p13.1 and is approximately 3 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 13 protein, plays a role in the regulation of both B cell development and apoptosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TNFSF13 wt Allele","conceptCode":"C105968","definition":"Human TNFSF13 wild-type allele is located in the vicinity of 17p13.1 and is approximately 3 kb in length. This allele, which encodes tumor necrosis factor ligand superfamily member 13 protein, plays a role in the regulation of both B cell development and apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B92ED-83C1-08C6-E053-731AD00A9836","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83C9-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Fascin","valueDescription":null,"ValueMeaning":{"publicId":"10625888","version":"1","preferredName":"Fascin","longName":"10625888v1.00","preferredDefinition":"Fascin (493 aa, ~55 kDa) is encoded by the human FSCN1 gene. This protein is involved in the formation of actin filaments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fascin","conceptCode":"C101607","definition":"Fascin (493 aa, ~55 kDa) is encoded by the human FSCN1 gene. This protein is involved in the formation of actin filaments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B92ED-83C2-08C6-E053-731AD00A9836","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83CA-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"CD163","valueDescription":null,"ValueMeaning":{"publicId":"3332540","version":"1","preferredName":"CD163 gene","longName":"3332540","preferredDefinition":"This gene plays a role in endocytosis by macrophages.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD163 Gene","conceptCode":"C104062","definition":"This gene plays a role in endocytosis by macrophages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3E568D4-B895-90F9-E040-BB89AD432C97","latestVersionIndicator":"Yes","beginDate":"2011-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-12-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83CB-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Cyclin D1","valueDescription":null,"ValueMeaning":{"publicId":"3234665","version":"1","preferredName":"CCND1 Gene","longName":"3234665","preferredDefinition":"This gene plays a role in the regulation of mitotic events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CCND1 Gene","conceptCode":"C18021","definition":"This gene plays a role in the regulation of mitotic events.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-13E6-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41B92ED-83CC-08C6-E053-731AD00A9836","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"CD14","valueDescription":null,"ValueMeaning":{"publicId":"3261439","version":"1","preferredName":"CD14 gene","longName":"3261439","preferredDefinition":"This gene plays a role in apoptosis and in ligand-binding interactions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD14 Gene","conceptCode":"C21290","definition":"This gene plays a role in apoptosis and in ligand-binding interactions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-675D-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-10","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41BA366-E973-0A72-E053-731AD00A57B3","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"CD3","valueDescription":null,"ValueMeaning":{"publicId":"3540239","version":"1","preferredName":"CD3 Complex","longName":"3540239","preferredDefinition":"Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD3 Complex","conceptCode":"C38897","definition":"A protein complex comprised of one T-cell surface glycoprotein CD3 delta chain (CD3D), one T-cell surface glycoprotein CD3 gamma chain (CD3G) and two T-cell surface glycoprotein CD3 epsilon chains (CD3E). CD3D, CD3G and CD3E are transmembrane proteins with one extracellular immunoglobulin domain and one intracellular ITAM domain. The CD3 complex is a T-cell co-receptor that noncovalently associates with either the disulfide bound heterodimeric alpha/beta T-cell receptor (TCR) or gamma/delta TCR and two copies of the accessory protein, T-cell surface glycoprotein CD3 zeta chain (CD247), which is a transmembrane protein with three ITAM domains. The TCR moiety of the TCR-CD3 complex binds to MHC and processed antigens on antigen presenting cells, which triggers phosphorylation of and cellular propagation of the signal by CD247 and the CD3 complex.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64D85C5-7557-4BF3-E040-BB89AD4309F1","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41BA366-E974-0A72-E053-731AD00A57B3","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"KI-67","valueDescription":null,"ValueMeaning":{"publicId":"3009658","version":"1","preferredName":"Proliferation-Related Ki-67 Antigen","longName":"3009658","preferredDefinition":"Antigen Identified by Monoclonal Antibody Ki-67, encoded by the MKI67 gene, is a nuclear antigen expressed in proliferating cells but not in quiescent cells, and required for maintaining cell proliferation. Expression of this antigen occurs preferentially during late G1, S, G2, and M phases of the cell cycle, while in cells in G0 phase the antigen cannot be detected. Consequently, the monoclonal antibody Ki-67 is used in tumor pathology to detect proliferating cells in neoplastic diseases. This antigen is located in the nucleus, predominantly localized in the G1 phase in the perinucleolar region. In the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix. In mitosis, it is present on all chromosomes. This antigen contains 1 FHA domain. Two alternative splicing forms exist, Long and Short. (from Swiss-Prot) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antigen KI-67","conceptCode":"C17675","definition":"Antigen KI-67 protein (3256 aa, ~359 kDa) is encoded by the human MKI67 gene. This protein is required for cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6AE9B9-9530-559F-E040-BB89AD437EAB","latestVersionIndicator":"Yes","beginDate":"2010-02-12","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-02-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41BA366-E975-0A72-E053-731AD00A57B3","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E41BA366-E976-0A72-E053-731AD00A57B3","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10625882","version":"1","preferredName":"Biomarker Type","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._Something distinguishable as an identifiable class based on common qualities.","longName":"10625882v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B5A2A-5F6B-01CA-E053-731AD00AD8B8","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"MMADDINENI","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41B5A2A-5F6C-01CA-E053-731AD00AD8B8","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":"2022.10.18 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What were the pharmacogenomic test biomarkers?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Immunostains or Biomarkers:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E41BBAEA-269C-0D4A-E053-731AD00A9EAB","latestVersionIndicator":"Yes","beginDate":"2022-07-18","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-07-18","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":"2022.10.18 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}